CBIO Market Cap History
Below is a table of the CBIO market cap history going back to 2/13/2017:

Date CBIO Market Cap

Also see: CBIO Shares Outstanding History
and CBIO YTD Return
CBIO Historical Market Cap:
+13.82% CAGR
CBIO Historical Market Cap: +13.82% CAGR

Mouse over chart for data details
2/13/2017 ...11/7/2022
Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development. We show 27 historical shares outstanding datapoints in our CBIO shares outstanding history coverage, used to compute CBIO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CBIO market cap history over the course of time is important for investors interested in comparing CBIO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CBIO versus a peer is one thing; comparing CBIO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CBIO can fluctuate over the course of history. With this page we aim to empower investors researching CBIO by allowing them to research the CBIO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Catalyst Biosciences (CBIO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CBLI Market Cap History
CBM Market Cap History
CBMG Market Cap History
CBPO Market Cap History
CCCC Market Cap History
CCEL Market Cap History
CCRN Market Cap History
CCXI Market Cap History
CDAK Market Cap History
CDMO Market Cap History
More Healthcare companies »


CBIO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.